575 related articles for article (PubMed ID: 12872001)
1. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
2. V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans.
Morelli F; Romeo M; Barzago MM; Bolis M; Mattioni D; Rossi G; Tagliavini F; Bastone A; Salmona M; Diomede L
Neurobiol Dis; 2018 Sep; 117():226-234. PubMed ID: 29936232
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans.
Kraemer BC; Burgess JK; Chen JH; Thomas JH; Schellenberg GD
Hum Mol Genet; 2006 May; 15(9):1483-96. PubMed ID: 16600994
[TBL] [Abstract][Full Text] [Related]
4. Progressive neurodegeneration in C. elegans model of tauopathy.
Miyasaka T; Ding Z; Gengyo-Ando K; Oue M; Yamaguchi H; Mitani S; Ihara Y
Neurobiol Dis; 2005 Nov; 20(2):372-83. PubMed ID: 16242642
[TBL] [Abstract][Full Text] [Related]
5. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
7. Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies.
Higuchi M; Zhang B; Forman MS; Yoshiyama Y; Trojanowski JQ; Lee VM
J Neurosci; 2005 Oct; 25(41):9434-43. PubMed ID: 16221853
[TBL] [Abstract][Full Text] [Related]
8. A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations
Bardai FH; Wang L; Mutreja Y; Yenjerla M; Gamblin TC; Feany MB
J Neurosci; 2018 Jan; 38(1):108-119. PubMed ID: 29138281
[TBL] [Abstract][Full Text] [Related]
9. Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model.
Pir GJ; Choudhary B; Mandelkow E; Mandelkow EM
Mol Neurodegener; 2016 Apr; 11():33. PubMed ID: 27118310
[TBL] [Abstract][Full Text] [Related]
10. Neurodegenerative tauopathy in the worm.
Goedert M
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9653-5. PubMed ID: 12913116
[No Abstract] [Full Text] [Related]
11. Transgenic animal models of tauopathies.
Lee VM; Kenyon TK; Trojanowski JQ
Biochim Biophys Acta; 2005 Jan; 1739(2-3):251-9. PubMed ID: 15615643
[TBL] [Abstract][Full Text] [Related]
12. Glutamatergic nervous system degeneration in a C. elegans Tau
Choudhary B; Mandelkow E; Mandelkow EM; Pir GJ
Neurobiol Dis; 2018 Sep; 117():189-202. PubMed ID: 29894752
[TBL] [Abstract][Full Text] [Related]
13. Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model.
Guha S; Fischer S; Johnson GVW; Nehrke K
Mol Neurodegener; 2020 Nov; 15(1):65. PubMed ID: 33168053
[TBL] [Abstract][Full Text] [Related]
14. Curcumin improves tau-induced neuronal dysfunction of nematodes.
Miyasaka T; Xie C; Yoshimura S; Shinzaki Y; Yoshina S; Kage-Nakadai E; Mitani S; Ihara Y
Neurobiol Aging; 2016 Mar; 39():69-81. PubMed ID: 26923403
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration.
Forman MS; Lal D; Zhang B; Dabir DV; Swanson E; Lee VM; Trojanowski JQ
J Neurosci; 2005 Apr; 25(14):3539-50. PubMed ID: 15814784
[TBL] [Abstract][Full Text] [Related]
17. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
[TBL] [Abstract][Full Text] [Related]
19. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Strang KH; Golde TE; Giasson BI
Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
[TBL] [Abstract][Full Text] [Related]
20. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
